Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | 1,117,408 | reported | 21 May 2026 | tx 84+5,515,479−1,672,933 |
| Talaris Therapeutics, Inc. | 20,500 | reported | 13 Jun 2023 | tx 2+35,001 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 76,490 | 1.69 USD | |
| 21 May 2026 | SALE | ROCKET PHARMACEUTICALS, INC. | 55,684 | 3.09 USD | |
| 21 May 2026 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 76,490 | 1.69 USD | deriv |
| 19 May 2026 | SALE | ROCKET PHARMACEUTICALS, INC. | 2,409 | 3.01 USD | |
| 13 May 2026 | SALE | ROCKET PHARMACEUTICALS, INC. | 2,728 | 3.61 USD | |
| 18 Feb 2026 | SALE | ROCKET PHARMACEUTICALS, INC. | 5,990 | 3.34 USD | |
| 13 Feb 2026 | SALE | ROCKET PHARMACEUTICALS, INC. | 12,279 | 3.31 USD | |
| 11 Feb 2026 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 286,028 | 0.00 USD | |
| 11 Feb 2026 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 870,648 | 0.00 USD | deriv |
| 18 Nov 2025 | SALE | ROCKET PHARMACEUTICALS, INC. | 6,276 | 2.98 USD | |
| 18 Aug 2025 | TAX_WITHHOLDING | ROCKET PHARMACEUTICALS, INC. | 2,234 | 3.05 USD | |
| 20 May 2025 | SALE | ROCKET PHARMACEUTICALS, INC. | 2,253 | 6.45 USD | |
| 16 May 2025 | SALE | ROCKET PHARMACEUTICALS, INC. | 3,621 | 6.53 USD | |
| 10 Apr 2025 | PURCHASE | ROCKET PHARMACEUTICALS, INC. | 20,000 | 5.08 USD | first after silence |
| 21 Feb 2025 | SALE | ROCKET PHARMACEUTICALS, INC. | 16,303 | 10.58 USD | |
| 11 Feb 2025 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 81,655 | 0.00 USD | |
| 11 Feb 2025 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 243,345 | 0.00 USD | deriv |
| 21 Nov 2024 | SALE | ROCKET PHARMACEUTICALS, INC. | 11,091 | 13.05 USD | |
| 16 Aug 2024 | SALE | ROCKET PHARMACEUTICALS, INC. | 9,650 | 18.50 USD | |
| 14 May 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 9,683 | 0.00 USD | |
| 16 May 2024 | SALE | ROCKET PHARMACEUTICALS, INC. | 9,790 | 23.35 USD | |
| 14 Feb 2023 | OTHER | ROCKET PHARMACEUTICALS, INC. | 67,785 | 0.00 USD | |
| 14 Feb 2022 | OTHER | ROCKET PHARMACEUTICALS, INC. | 23,940 | 0.00 USD | |
| 14 May 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 7,979 | 0.00 USD | |
| 14 May 2024 | EXERCISE | ROCKET PHARMACEUTICALS, INC. | 9,683 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 10 Apr 2025.